{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T11:14:20Z","timestamp":1791630860171,"version":"4.3.4"},"reference-count":39,"publisher":"American Chemical Society (ACS)","issue":"11","license":[{"start":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T00:00:00Z","timestamp":1633564800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T00:00:00Z","timestamp":1633564800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T00:00:00Z","timestamp":1633564800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"name":"Nagai foundation Tokyo"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol. Pharmaceutics"],"published-print":{"date-parts":[[2021,11,1]]},"DOI":"10.1021\/acs.molpharmaceut.1c00537","type":"journal-article","created":{"date-parts":[[2021,10,8]],"date-time":"2021-10-08T01:48:46Z","timestamp":1633657726000},"page":"4122-4130","source":"Crossref","is-referenced-by-count":26,"title":["In Vitro\u2013In Vivo Correlation in Cocrystal Dissolution: Consideration of Drug Release Profiles Based on Coformer Dissolution and Absorption Behavior"],"prefix":"10.1021","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5349-3174","authenticated-orcid":true,"given":"Makoto","family":"Kataoka","sequence":"first","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Setsunan University, Hirakata, Osaka 573-0101, Japan"},{"name":"College of Pharmacy, University of Michigan, Ann Arbor, Michigan 498109-1065, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4867-9361","authenticated-orcid":true,"given":"Keiko","family":"Minami","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Setsunan University, Hirakata, Osaka 573-0101, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1199-4015","authenticated-orcid":true,"given":"Toshihide","family":"Takagi","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Setsunan University, Hirakata, Osaka 573-0101, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory E.","family":"Amidon","sequence":"additional","affiliation":[{"name":"College of Pharmacy, University of Michigan, Ann Arbor, Michigan 498109-1065, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6443-9958","authenticated-orcid":true,"given":"Shinji","family":"Yamashita","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Setsunan University, Hirakata, Osaka 573-0101, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2021,10,7]]},"reference":[{"key":"ref1\/cit1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2007.05.010"},{"key":"ref2\/cit2","doi-asserted-by":"publisher","DOI":"10.1002\/jps.20932"},{"key":"ref3\/cit3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2012.05.040"},{"key":"ref4\/cit4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2015.05.015"},{"key":"ref5\/cit5","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-012-9389-7"},{"key":"ref6\/cit6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2018.04.014"},{"key":"ref7\/cit7","doi-asserted-by":"publisher","DOI":"10.1007\/s13346-018-0582-9"},{"key":"ref8\/cit8","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-013-1126-0"},{"key":"ref9\/cit9","unstructured":"US Food and\nDrug Administration,\nGuidance for industry, Regulatory Classification of Pharmaceutical\nCo-Crystals. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/regulatory-classification-pharmaceutical-co-crystals, 2018 (accessed July 4, 2021)."},{"key":"ref10\/cit10","doi-asserted-by":"publisher","DOI":"10.1021\/ja035776p"},{"key":"ref11\/cit11","doi-asserted-by":"publisher","DOI":"10.1021\/cg0496540"},{"key":"ref12\/cit12","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-008-9676-2"},{"key":"ref13\/cit13","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.2010.01189.x"},{"key":"ref14\/cit14","doi-asserted-by":"publisher","DOI":"10.1021\/mp400176y"},{"key":"ref15\/cit15","doi-asserted-by":"publisher","DOI":"10.1021\/acs.cgd.6b01425"},{"key":"ref16\/cit16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2012.01.017"},{"key":"ref17\/cit17","doi-asserted-by":"publisher","DOI":"10.1002\/jps.24690"},{"key":"ref18\/cit18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2017.06.011"},{"key":"ref19\/cit19","doi-asserted-by":"publisher","DOI":"10.1023\/a:1018918316253"},{"key":"ref20\/cit20","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2000.63.270"},{"key":"ref21\/cit21","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-114-9-755"},{"key":"ref22\/cit22","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01034-08"},{"key":"ref23\/cit23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1993.tb00103.x"},{"key":"ref24\/cit24","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-011-0506-6"},{"key":"ref25\/cit25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2016.09.014"},{"key":"ref26\/cit26","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.9b01178"},{"key":"ref27\/cit27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.120441"},{"key":"ref28\/cit28","doi-asserted-by":"publisher","DOI":"10.1021\/acs.cgd.9b01026"},{"key":"ref29\/cit29","doi-asserted-by":"publisher","DOI":"10.1021\/mp050099m"},{"key":"ref30\/cit30","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2016.10.008"},{"key":"ref31\/cit31","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600801114"},{"key":"ref32\/cit32","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxrep.2020.01.004"},{"key":"ref33\/cit33","doi-asserted-by":"publisher","DOI":"10.1021\/cg049954h"},{"key":"ref34\/cit34","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2017.08.002"},{"key":"ref35\/cit35","doi-asserted-by":"publisher","DOI":"10.1021\/mp400465p"},{"key":"ref36\/cit36","doi-asserted-by":"publisher","DOI":"10.2165\/11319340-000000000-00000"},{"key":"ref37\/cit37","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02931-15"},{"key":"ref38\/cit38","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.1.160-165.2002"},{"key":"ref39\/cit39","unstructured":"US Food and Drug Administration\n(FDA). Center for Drug Evaluation and Research.\nDrugs@FDA: FDA approved drug products. Search results for \u201csporanox.\u201d\nAvailable at: http:\/\/www.accessdata.fda.gov\/scripts\/cder\/drugsatfda\/index.cfm (accessed July 4, 2021)."}],"container-title":["Molecular Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.molpharmaceut.1c00537","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T18:34:40Z","timestamp":1682620480000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/doi\/10.1021\/acs.molpharmaceut.1c00537"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,7]]},"references-count":39,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11,1]]}},"alternative-id":["10.1021\/acs.molpharmaceut.1c00537"],"URL":"https:\/\/doi.org\/10.1021\/acs.molpharmaceut.1c00537","relation":{},"ISSN":["1543-8384","1543-8392"],"issn-type":[{"value":"1543-8384","type":"print"},{"value":"1543-8392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,7]]}}}